8 completed, 1 active not recruiting, 1 recruiting. 10 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 10 | Completed 8, Active not recruiting 1, Recruiting 1 |
| Phase 1 | 1 | Completed 1 |
Follow Myeloproliferative Disorder: new trials by email Literature Review of Myeloproliferative Disorder trials Research Report on Myeloproliferative Disorder
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Cord Blood Transplant in Adults With Blood Cancers Conditioning Chemotherapy, Cord blood graft - Acute Myelogenous Leukemia (AML), Acute Lymphoblastic Leukemia (ALL) | Phase 2 | Active not recruiting | Memorial Sloan Kettering Cancer Center | 17 | 2023-05-22 | 2026-10-23 |
| Allogeneic Hematopoietic Cell Transplantation From HLA-matched Donor After Flu-Mel-PTCy Versus Flu-Mel-ATG Reduced-intensity Conditioning Thymoglobulin, Melphalan, Fludarabine - Acute Myeloid Leukemia in Remission, Myelodysplastic Syndromes | Phase 2 | Recruiting | University of Liege | 114 | 2019-02-04 | 2022-10-12 |
| Total Body Irradiation +/- Total Lymphoid Irradiation & Anti-Thymocyte Globulin in Non-myeloablative Hematopoietic Cell Transplantation Total body irradiation (TBI), Anti-thymocyte globulin (ATG), Tacrolimus - Acute Myeloid Leukemia, Myelodysplastic Syndromes | Phase 2 | Completed | Stanford University | 22 | 2018-11-05 | 2023-12-12 |
| Tocilizumab for the Prevention of Graft Versus Host Disease After Cord Blood Transplantation Total Body Irradiation, Cyclosporine, Mycophenolate Mofetil - Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia | Phase 2 | Completed | Memorial Sloan Kettering Cancer Center | 46 | 2018-02-07 | 2026-05-26 |
| Fungal Prophylaxis With Isavuconazole for Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplant (HCT) Isavuconazole - Hematologic Malignancy, Myeloproliferative Disorder | Phase 2 | Completed | Memorial Sloan Kettering Cancer Center | 99 | 2017-05-04 | 2025-05-16 |
| Preventing Stem Cell Transplant Complications With a Blood Separator Machine Graft Manipulation (CD34+ Selection) - MDS (Myelodysplastic Syndrome), Myeloproliferative Disorder | Phase 1 / Phase 2 | Completed | National Heart, Lung, and Blood Institute (NHLBI) | 41 | 2013-05-29 | 2020-07-21 |
| Low Dose IL-2, Hematopoietic Stem Cell Transplantation, IL2 for GVHD IL-2 - Acute Lymphoblastic Leukemia, ALL | Phase 2 | Completed | Baylor College of Medicine | 25 | 2007-06-01 | 2018-05-04 |
| Phase II Trial of Gemcitabine, Carboplatin, and Bevacizumab in Chemotherapy Naive Patients With Advanced/Metastatic Urothelial Carcinoma Bevacizumab, Carboplatin, Gemcitabine - Myeloproliferative Disorder, Urothelial Carcinoma | Phase 2 | Completed | Memorial Sloan Kettering Cancer Center | 51 | 2006-05-01 | 2016-01-22 |
| Nonmyeloablative Allogeneic Stem Cell Transplantation From HLA-Matched Unrelated Donor for the Treatment of Hematologic Disorders Cyclophosphamide; Fludarabine; Cyclosporin; CAMPATH-1H (Alemtuzumab); GM-CSF - AML, ALL | Phase 2 | Completed | Beth Israel Deaconess Medical Center | 25 | 2002-12-01 | 2016-07-18 |
| T-Cell Depleted Allogeneic Stem Cell Transplantation for Patients With Hematologic Malignancies Fludarabine, Melphalan, Stem cells - Acute Myelogenous Leukemia, Lymphoid Leukemia | Phase 2 | Completed | University of Chicago | 204 | 2001-11-01 | 2016-11-22 |
Myeloproliferative Disorders (10) · Myelodysplastic Syndromes (8) · Lymphoma, Non-Hodgkin (7) · Hodgkin Disease (6) · Leukemia, Myeloid, Acute (6) · Leukemia, Myelogenous, Chronic, BCR-ABL Positive (4) · Precursor Cell Lymphoblastic Leukemia-Lymphoma (4) · Leukemia, Lymphocytic, Chronic, B-Cell (3) · Anemia, Aplastic (2) · Hematologic Neoplasms (2) · Multiple Myeloma (2) · Anemia, Refractory, with Excess of Blasts (1) · Blast Crisis (1) · Carcinoma, Transitional Cell (1) · Graft vs Host Disease (1)
Bone Marrow Diseases (10) · Hematologic Diseases (10) · Hemic and Lymphatic Diseases (10) · Neoplasms (9) · Neoplasms by Histologic Type (9) · Immune System Diseases (8) · Immunoproliferative Disorders (8) · Lymphatic Diseases (8) · Lymphoproliferative Disorders (8) · Lymphoma (7) · Leukemia (6) · Leukemia, Lymphoid (6) · Leukemia, Myeloid (6) · Pathologic Processes (6) · Pathological Conditions, Signs and Symptoms (6)
fludarabine (3) · Alemtuzumab (2) · Cyclophosphamide (2) · Cyclosporine (2) · Melphalan (2) · Mycophenolic Acid (2) · Whole-Body Irradiation (2) · Antilymphocyte Serum (1) · Bevacizumab (1) · Carboplatin (1) · Filgrastim (1) · Gemcitabine (1) · Granulocyte Colony-Stimulating Factor (1) · Granulocyte-Macrophage Colony-Stimulating Factor (1) · Interleukin-2 (1)
Memorial Sloan Kettering Cancer Center (4) · Baylor College of Medicine (1) · Beth Israel Deaconess Medical Center (1) · National Heart, Lung, and Blood Institute (NHLBI) (1) · Stanford University (1) · University of Chicago (1) · University of Liege (1)
United States (9) · Belgium (1)
Andrew Artz, MD (1) · Ann Jakubowski, MD (1) · David E Avigan, MD (1) · David F McDermott, MD (1) · Dean Bajorin, MD (1) · Ioannis Politikos, MD (1) · Rayne Rouce, MD (1) · Robert Lowsky, MD (1) · Sawa Ito, M.D. (1)
2017 (1)